==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 28
IDThPPIDNamePeptide SequenceLengthFunctional ClassificationDiseaseBrandCompanyPhysical AppearanceRoute of AdministartionCategoryTarget
1385Th1061TrastuzumabLight chain 1: DIQMT Full view1364IIaCancerHerceptinGenentechSterile, white to pale yellow, preservative-free lyophilized powder Intravenous administrationAntineoplastic Agents Insulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
1412Th1068TositumomabHeavy Chain 1: QAYLQ Full view1351IIbCancerBexxarGalaxo Smith KlineSterile, pyrogen-free, clear to opalescent, colorless to slightly yellow, preservative-free solution Intravenous(IV) administrationN.A. Bacterial outer membrane,Lipoteichoic acid synthesis
1419Th1070Botulinum Toxin Type AMPFVNKQFNYKDPVNGVDIA Full view1296IcNeurological DisorderBOTOX AllerganSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type AIntramuscular, intradetrusor and intradermal useNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents Growth hormone receptor
1420Th1070Botulinum Toxin Type AMPFVNKQFNYKDPVNGVDIA Full view1296IcNeurological DisorderDysportIpsen PharmaceuticalsSterile vial for reconstitutionIntramuscular InjectionNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents Growth hormone receptor
1421Th1070Botulinum Toxin Type AMPFVNKQFNYKDPVNGVDIA Full view1296IcNeurological DisorderXeominMERZ AESTHETICSSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection.Intramuscular InjectionNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents Growth hormone receptor
1422Th1071PancrelipasePancreatic alpha amy Full view1206IaMetabolic/genetic/PancrecarbDigestive care US, Inc.Delayed-Release Capsules, Buffered and Enteric-Coated Microspheres.Oral routeGastrointestinal Agents and Enzyme Replacement Agents Synaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
1423Th1071PancrelipasePancreatic alpha amy Full view1206IaMetabolic/genetic/ViokaceAptalis Pharma US, Inc.Beige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet formOral routeGastrointestinal Agents and Enzyme Replacement Agents Synaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
1424Th1071PancrelipasePancreatic alpha amy Full view1206IaMetabolic/genetic/ULTRESAAptalis Pharma US, Inc.Beige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether and converted to Delayed-Release CapsulesOral routeGastrointestinal Agents and Enzyme Replacement Agents Synaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
1425Th1071PancrelipasePancreatic alpha amy Full view1206IaMetabolic/genetic/PERTZYEDigestive care US, Inc.Beige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether PERTZYE delayed-release capsuleOral routeGastrointestinal Agents and Enzyme Replacement Agents Synaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
1426Th1071PancrelipasePancreatic alpha amy Full view1206IaMetabolic/genetic/ULTRASEAxcan PharmaCapsules Enteric-Coated MicrospheresOral routeGastrointestinal Agents and Enzyme Replacement Agents Synaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
1427Th1071PancrelipasePancreatic alpha amy Full view1206IaMetabolic/genetic/ZENPEPAptalis Pharma US, Inc.Delayed-Release CapsulesOral routeGastrointestinal Agents and Enzyme Replacement Agents Synaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
1470Th1092ArcitumomabHeavy chain 1EVKLVES Full view1310IIbCancerCEA-ScanN.A.N.A.N.A.Diagnostic Agents Vascular endothelial growth factor A,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Carcinoembryonic antigen-related cell adhesion molecule 1
1477Th1097Alglucosidase AlfaAHPGRPRAVPTQCDVPPNSR Full view882IcMetabolicLUMIZYMEGenzymeSterile, nonpyrogenic, white to off-white, lyophilized cake or powder for reconstitution with 10.3 Ml Sterile Water for Injection, USPIntravenous infusionEnzyme Replacement Agents Cation-dependent mannose-6-phosphate receptor,Glycogen
1533Th1112Natural Alpha Interferon Or MultiferonInteferon alpha-1: Full view997IIaCancer/InfectiousIntron/ Roferon-AN.A.N.A.Subcutaneous injection, Intravenous injection, Intramuscular injectionN.A. N.A.
1537Th1116CanakinumabH-GAMMA-1 (VH(1-118) Full view842IIIbImmunologicalILARIS Novartis PharmaceuticalsWhite, preservative-free, lyophilized powderSubcutaneous injectionAnti-Inflammatory Agents and Monoclonal antibodies Interleukin-1 beta
1562Th1122Rilonaceptrilonacept|Homo sapi Full view880IIaImmunologicalArcalystRegeneron PharmaceuticalsSterile, white to off-white, lyophilized powderSubcutaneous injectionImmunosuppressive Agents Interleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
1673Th1160Satumomab PendetideHeavy Chain 1: QVQLQ Full view1299IVDiagnostic AgentsOncoScintCytogen Corp, Lonza BiologicsN.A.Intravenous InjectionDiagnostic Agents Tumor-associated glycoprotein 72 (TAG-72)
1785Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersBivigamKedrion Biopharma, Inc.Injection, SolutionIntravenousImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1786Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersBivigamBiotest Pharmaceuticals CorporationInjection, SolutionIntravenousImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1788Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersCarimune NanofilteredCsl Behring AgInjection, Powder, Lyophilized, for SolutionIntravenousImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1791Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersFlebogamma DifGRIFOLS USA, LLCInjection, SolutionIntravenousImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1793Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersGamastanCutter Med & Biol, Division Of Miles Canada Ltd.liquidIntramuscularImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1794Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersGamastan S/dGRIFOLS USA, LLCInjectionIntramuscularImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1795Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersHyqviaBaxalta Us Inc.LiquidIntravenous infusionImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1796Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersIveegam Immuno 5000mg (iv)Baxter AgNANAImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1805Th1199Ramucirumabramucirumab|Homo sap Full view909IIIcCancerCyramzaEli Lilly and CompanySolutionIntravenousAntineoplastic and Immunomodulating Agents Vascular endothelial growth factor receptor 2
1832Th1222Canakinumab H-GAMMA-1 Chain: QVQ Full view842IIaImmunological DisordersIlarisNovartisLyphilized powderSubcutaneousAntineoplastic and Immunomodulating Agents Interleukin-1 beta
1851Th1238Susoctocog alfaAIRRYYLGAVELSWDYRQSE Full view1448IbHematological DisordersObizurNAPowder and solvent for solution for injection.IntravenousBlood coagulation factors, Antihaemorrhagics von Willebrand factor